As of 2026-03-27, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -0.69 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of Biovaxys Technology Corp is -861.19%.
Based on its market price of 0.09 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 861.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.69 - -0.69 | -0.69 | -861.19% |
| P/E | (0.01) - (0.01) | (0.01) | -107.6% |
| DDM - Stable | (2.19) - (39.76) | (20.98) | -23408.4% |
| DDM - Multi | (1.44) - (20.20) | (2.68) | -3081.7% |
| Market Cap (mil) | 3.97 |
| Beta | 2.38 |
| Outstanding shares (mil) | 44.09 |
| Enterprise Value (mil) | 4.10 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.34% |
| Cost of Debt | 5.00% |
| WACC | 6.29% |